Quick search
Advanced search in
Field to searchTerm
Add rule
Filters (4)
Download Results
10 research outcomes, page 1 of 1
  • publication . Article . 2021
    Open Access English
    Authors:
    David A. Sack; Amanda K. Debes; Jerome Ateudjieu; Godfrey Bwire; Mohammad Ali; Moise Chi Ngwa; John Mwaba; Roma Chilengi; Christopher C Orach; Waqo Boru; ...
    Persistent Identifiers
    Publisher: Oxford University Press

    Studies of the epidemiology of cholera in the Ganges Delta led to understanding cholera's transmission patterns, risk groups, seasonality, and the relationship of cholera with the environment. In Bangladesh and West Bengal cholera is seasonal, transmission occurs consis...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Roland Bamou; Martin K. Rono; Teshome Degefa; Janet Midega; Charles Mbogo; Prophet Ingosi; Alice Kamau; Argaw Ambelu; Zewdie Birhanu; Kora Tushune; ...
    Persistent Identifiers
    Publisher: Oxford University Press (OUP)

    Abstract Introduction In order to improve our understanding of the fundamental limits of core interventions and guide efforts based on prioritization and identification of effective/novel interventions with great potentials to interrupt persistent malaria transmission ...

    Add to ORCIDorcid
  • publication . Article . Other literature type . 2019
    Open Access English
    Authors:
    Victor Chaumeau; Ladda Kajeechiwa; Bénédicte Fustec; Jordi Landier; Saw Naw Nyo; Saw Nay Hsel; Phabele Phatharakokordbun; Prapan Kittiphanakun; Suphak Nosten; May Myo Thwin; ...
    Persistent Identifiers
    Publisher: HAL CCSD
    Countries: United States, France
    Project: WT | Eliminating malaria to co... (101148)

    Abstract Background The objective of mass antimalarial drug administration (MDA) is to eliminate malaria rapidly by eliminating the asymptomatic malaria parasite reservoirs and interrupting transmission. In the Greater Mekong Subregion, where artemisinin-resistant Plasm...

    Add to ORCIDorcid
  • publication . Article . 2017
    Open Access English
    Authors:
    Lisa Menning; Gaurav Garg; Deepa Risal Pokharel; Elizabeth Thrush; Margaret Farrell; Frederic Kunjbe Kodio; Chantal Laroche Veira; Sarah Wanyoike; Suleman Malik; Manish M. Patel; ...
    Persistent Identifiers
    Publisher: Oxford University Press

    Abstract The requirements under objective 2 of the Polio Eradication and Endgame Strategic Plan 2013–2018—to introduce at least 1 dose of inactivated poliomyelitis vaccine (IPV); withdraw oral poliomyelitis vaccine (OPV), starting with the type 2 component; and strength...

    Add to ORCIDorcid
  • publication . Article . 2017
    Open Access English
    Authors:
    Reina S. Sikkema; Elmoubasher Farag; Sayed Himatt; Adel K Ibrahim; Hamad Al-Romaihi; Salih A. Al-Marri; Mohamed H. Al-Thani; Ahmed M. El-Sayed; Mohammed Al-Hajri; Bart L. Haagmans; ...
    Persistent Identifiers
    Publisher: Oxford University Press
    Project: EC | PREPARE (602525), EC | COMPARE (643476)

    Abstract The transmission routes and risk factors for zoonotic Middle East respiratory syndrome coronavirus (MERS-CoV) infections are still unknown. We used the World Health Organization questionnaire for MERS-CoV case-control studies to assess risk factors for human ME...

    Add to ORCIDorcid
  • publication . Article . 2017
    Open Access English
    Authors:
    Phillips, Andrew N.; Stover, John; Cambiano, Valentina; Nakagawa, Fumiyo; Jordan, Michael R.; Pillay, Deenan; Doherty, Meg; Revill, Paul; Bertagnolio, Silvia;
    Persistent Identifiers
    Publisher: Oxford University Press

    Abstract To inform the level of attention to be given by antiretroviral therapy (ART) programs to HIV drug resistance (HIVDR), we used an individual-level model to estimate its impact on future AIDS deaths, HIV incidence, and ART program costs in sub–Saharan Africa (SSA...

    Add to ORCIDorcid
  • publication . Article . 2016
    Open Access English
    Authors:
    Warigon, Charity; Mkanda, Pascal; Muhammed, Ado; Etsano, Andrew; Korir, Charles; Bawa, Samuel; Gali, Emmanuel; Nsubuga, Peter; Erbeto, Tesfaya B.; Gerlong, George; ...
    Persistent Identifiers
    Publisher: Oxford University Press

    Poliomyelitis has remained endemic in 3 countries in 2 regions of the World Health Organization (WHO), resulting in continued shifting of the target date for global eradication. By the end of 2011, polio remained a global threat despite the availability of oral polio va...

    Add to ORCIDorcid
  • publication . Article . 2016
    Open Access English
    Authors:
    Kehinde Craig; Harish Verma; Zubairu Iliyasu; Pascal Mkanda; Kebba Touray; Ticha Johnson; Abdullahi Walla; Richard Banda; Sisay G. Tegegne; Yared G. Yehualashet; ...
    Persistent Identifiers
    Publisher: Oxford University Press
    Country: United Kingdom

    In 1988, the World Health Assembly resolved to eradicate poliomyelitis by 2000 [1]. Subsequently, the Global Polio Eradication Initiative (GPEI) was able to reduce the number of polio-endemic countries and wild poliovirus (WPV) cases from 125 and 350 000, respectively, ...

    Add to ORCIDorcid
  • publication . Article . 2016
    Open Access English
    Authors:
    Yared G. Yehualashet; Alieu Wadda; Koffi B. Agblewonu; Theophilus Zhema; Al-asi A. Ibrahim; Alhagie Corr; Jennifer Linkins; Pascal Mkanda; Rui G. Vaz; Peter Nsubuga; ...
    Persistent Identifiers
    Publisher: Oxford University Press

    Nigeria is a federal republic with 36 states and a federal capital territory. There are 774 local government authorities (LGAs) and 9565 wards across the nation. Based on the last census, held in 2006, the country had a projected population of >170 million in 2014, whic...

    Add to ORCIDorcid
  • publication . Article . 2012
    Open Access English
    Authors:
    Montefiori, D. C.; Karnasuta, C.; Huang, Y.; Ahmed, H.; Gilbert, P.; de Souza, M. S.; McLinden, R.; Tovanabutra, S.; Laurence-Chenine, A.; Sanders-Buell, E.; ...
    Persistent Identifiers
    Publisher: Oxford University Press

    It is widely believed that a neutralizing antibody (NAb) response of sufficient magnitude, breadth, and duration would be highly beneficial for human immunodeficiency virus type 1 (HIV-1) vaccines [1–3]. Indeed, Nabs protect against experimental challenge with simian hu...

    Add to ORCIDorcid
10 research outcomes, page 1 of 1